Tumor-infiltrating lymphocytes make inroads in non-small-cell lung cancer
Nat Med
.
2021 Aug;27(8):1339-1341.
doi: 10.1038/s41591-021-01445-z.
Authors
Joshua R Veatch
1
2
,
Sylvain Simon
1
,
Stanley R Riddell
3
4
Affiliations
1
Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
2
University of Washington, Seattle, WA, USA.
3
Fred Hutchinson Cancer Research Center, Seattle, WA, USA. sriddell@fredhutch.org.
4
University of Washington, Seattle, WA, USA. sriddell@fredhutch.org.
PMID:
34385706
DOI:
10.1038/s41591-021-01445-z
No abstract available
Publication types
Comment
MeSH terms
Biomarkers, Tumor
CD8-Positive T-Lymphocytes
Carcinoma, Non-Small-Cell Lung* / drug therapy
Carcinoma, Non-Small-Cell Lung* / genetics
Humans
Lung Neoplasms* / drug therapy
Lymphocytes, Tumor-Infiltrating
Substances
Biomarkers, Tumor